631
Views
4
CrossRef citations to date
0
Altmetric
Review

An update on the emerging approaches for histone deacetylase (HDAC) inhibitor drug discovery and future perspectives

, &
Pages 745-761 | Received 26 Nov 2020, Accepted 14 Jan 2021, Published online: 02 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

S. M. Esther Rubavathy, Kandhan Palanisamy, S. Priyankha, Ramasamy Thilagavathi, Muthuramalingam Prakash & Chelliah Selvam. (2023) Discovery of novel HDAC8 inhibitors from natural compounds by in silico high throughput screening. Journal of Biomolecular Structure and Dynamics 41:19, pages 9492-9502.
Read now
Muhamad Mustafa & Jean-Yves Winum. (2022) The importance of sulfur-containing motifs in drug design and discovery. Expert Opinion on Drug Discovery 17:5, pages 501-512.
Read now

Articles from other publishers (2)

Jose R. Cortes, Christina C. Patrone, Stuart Aidan Quinn, Yuhan Gu, Marta Sanchez-Martin, Adam Mackey, Anisha J. Cooke, Bobby B. Shih, Anouchka P. Laurent, Megan H. Trager, Adolfo A. Ferrando, Larisa J. Geskin & Teresa Palomero. (2021) Jak-STAT Inhibition Mediates Romidepsin and Mechlorethamine Synergism in Cutaneous T-Cell Lymphoma. Journal of Investigative Dermatology 141:12, pages 2908-2920.e7.
Crossref
Rini Varghese & Anuradha Majumdar. (2021) Current Therapies in Nephrotic Syndrome: HDAC inhibitors, an Emerging Therapy for Kidney Diseases. Current Research in Biotechnology 3, pages 182-194.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.